Novo Holdings, the majority owner of Novo Nordisk and Novozymes, aims to grow into a much larger real estate player in the Scandinavian market, forecasts Novo Holdings Managing Partner Morten Beck Jørgensen from the company's financial investment unit, which has just ventured DKK 1 billion (EUR 130 million) in a new fund launched by Nordic Real Estate Partners and concurrently purchased a 25-percent stake in NREP.
This fund investment sets the value of Novo Holdings' combined real estate assets to around DKK 4 billion – but that's not enough.
Already a subscriber? Log in.
Read the whole article
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.Start a free company trial today
Your trial for AMWatch has now started
With your free trial you get:
Full access to all locked articles on AMWatch.
Daily newsletter and ongoing top-newsletters. You can unsubscribe and subscribe to our newsletters anytime.
When your trial period expires
You will not be transferred to a paid subscription.
You will continue to receive our newsletters after the trial period expires. You can unsubscribe at the bottom of each newsletter.